Literature DB >> 19470830

Plasma membrane depolarization as a determinant of the first phase of insulin secretion.

K Hatlapatka1, M Willenborg, I Rustenbeck.   

Abstract

The role of plasma membrane depolarization as a determinant of the initial phase of insulin secretion was investigated. NMRI mouse islets and beta-cells were used to measure the kinetics of insulin secretion, ATP and ADP content, membrane potential, and cytosolic free Ca(2+) concentration ([Ca(2+)](i)). The depolarization of metabolically intact beta-cells by KCl corresponded closely to the theoretical values. In contrast to physiological (glucose) or pharmacological (tolbutamide) ATP-sensitive K(+) (K(ATP)) channel block, KCl depolarization did not induce action potential spiking. The depolarization by 15 mM K(+) (21 mV) corresponded to the plateau depolarization by 50 or 500 microM tolbutamide; that by 40 mM K(+) (41 mV) corresponded to the action potential peaks. Nifedipine and diazoxide abolished action potentials but not KCl depolarization, suggesting that the depolarizing strength of 15, but not 40 mM K(+) corresponds to that of K(ATP) channel closure. K(+) (40 mM) induced a massive secretory response in the presence of 5 mM glucose, whereas 15 mM K(+), like 50 microM tolbutamide, was only slightly effective, even though a marked increase in [Ca(2+)](i) was produced. Raising glucose from 5 to 10 mM in the continued presence of 15 mM K(+) resulted in a strongly enhanced biphasic response. The depolarization pattern of this combination could be mimicked by combining basal glucose with 15 mM K(+) and 50 microM tolbutamide; however, the secretory response to these nonnutrients was much weaker. In conclusion, the initial secretory response to nutrient secretagogues is largely influenced by signaling mechanisms that do not involve depolarization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470830     DOI: 10.1152/ajpendo.90981.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  19 in total

1.  TASK-1 Potassium Channels Limit Pancreatic α-Cell Calcium Influx and Glucagon Secretion.

Authors:  Prasanna K Dadi; Brooke Luo; Nicholas C Vierra; David A Jacobson
Journal:  Mol Endocrinol       Date:  2015-04-07

2.  Late sodium current (INaL) in pancreatic β-cells.

Authors:  Riccardo Rizzetto; Marcella Rocchetti; Luca Sala; Carlotta Ronchi; Alice Villa; Mara Ferrandi; Isabella Molinari; Federico Bertuzzi; Antonio Zaza
Journal:  Pflugers Arch       Date:  2014-09-20       Impact factor: 3.657

3.  Differential phosphorylation of RhoGDI mediates the distinct cycling of Cdc42 and Rac1 to regulate second-phase insulin secretion.

Authors:  Zhanxiang Wang; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

4.  Role of Serotonin (5-HT) in GDM Prediction Considering Islet and Liver Interplay in Prediabetic Mice during Gestation.

Authors:  Melissa Asuaje Pfeifer; Moritz Liebmann; Till Beuerle; Katharina Grupe; Stephan Scherneck
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

5.  Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model.

Authors:  Moritz Liebmann; Melissa Asuaje Pfeifer; Katharina Grupe; Stephan Scherneck
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

6.  Pancreatic β-cell-specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance.

Authors:  Prasanna K Dadi; Nicholas C Vierra; David A Jacobson
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

7.  Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion.

Authors:  Jessica Houtz; Philip Borden; Alexis Ceasrine; Liliana Minichiello; Rejji Kuruvilla
Journal:  Dev Cell       Date:  2016-11-07       Impact factor: 12.270

8.  Assessment of re-aggregated human pancreatic islets for secondary drug screening.

Authors:  K Ramachandran; X Peng; K Bokvist; L Stehno-Bittel
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 9.  What Is the Metabolic Amplification of Insulin Secretion and Is It (Still) Relevant?

Authors:  Ingo Rustenbeck; Torben Schulze; Mai Morsi; Mohammed Alshafei; Uwe Panten
Journal:  Metabolites       Date:  2021-06-02

10.  Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion.

Authors:  Nicholas H F Fine; Craig L Doig; Yasir S Elhassan; Nicholas C Vierra; Piero Marchetti; Marco Bugliani; Rita Nano; Lorenzo Piemonti; Guy A Rutter; David A Jacobson; Gareth G Lavery; David J Hodson
Journal:  Diabetes       Date:  2017-12-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.